An Israeli-led international team of researchers has proof of concept for a single blood test that can detect multiple conditions, including diabetes, cancer, traumatic injury and neurodegeneration, in a highly sensitive and specific manner.
The novel method, tested on 320 patients and control groups, zeroes in on patterns of circulating DNA that is released by dying cells and traces it to specific types of tissue.
The study was reported in a paper published recently in the journal
Proceedings of National Academy of Sciences USA.
Cell death can signify the early stages of pathology (such as a developing tumor or the beginning of an autoimmune or neurodegenerative disease), mark disease progression, reflect the success of therapy (such as anti-cancer drugs), identify unintended toxic effects of treatment and more.
More...ISRAEL21c——
Bio and Archives
ISRAEL21c was founded in 2001, in the wake of the Second Intifada, to broaden public understanding of Israel beyond typical portrayals in the mainstream media.
The organization’s founders – Israeli-American technology executives – understood the great power of the Internet and developed a first-of-its kind online product with global appeal and reach.
